We limit data available in the Overview Report for users who do not have Powerpack
Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.
Target Price Range
Recommendation Rating
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 2.06 | 2.16 | 2.04 | 1.31 | — | — | — |
Low Price
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.16 | 3.35 | 3.01 | 2.69 | — | — | — |
High Price
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 564 | 519 | 564 | 468 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.08 | 0.11 | 0.10 | 0.22 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 43.63 | 56.31 | 57.78 | 102.44 | — | — | — |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 32.20% | 45.21% | 43.08% | 33.53% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (228.03) | (55.60) | (99.46) | (107.56) | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (522.61%) | (98.73%) | (172.15%) | (105.00%) | — | — | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (228.29) | (55.66) | (99.86) | (100.35) | — | — | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.28 | 6.54 | 2.64 | 20.46 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.17 | 0.23 | 0.26 | 0.47 | — | — | — |
Revenue/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.88) | (0.22) | (0.44) | (1.36) | — | — | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.36) | (0.42) | (0.09) | (0.33) | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.04) | (0.04) | (0.01) | 0.00 | — | — | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.39) | (0.47) | (0.10) | (0.33) | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.46 | 4.10 | 3.94 | 2.56 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 257.79 | 248.02 | 218.31 | 215.74 | — | — | — |
Shares
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
PE Ratio
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.71 | 10.31 | 9.37 | 3.24 | — | — | — |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.52 | 0.57 | 0.63 | 0.60 | — | — | — |
PB Ratio
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (9.82) | (4.81) | (3.75) | (1.22) | — | — | — |
EV/Sales
|
| ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.22 | 2.27 | 9.93 | 1.74 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (92.05) | (105.07) | (18.92) | (70.27) | — | — | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (9.39) | (10.62) | (2.91) | (1.06) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (101.44) | (115.69) | (21.83) | (71.33) | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,027.29 | 859.52 | 759.22 | 473.34 | — | — | — |
Working Cap'
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.74 | 0.63 | 0.41 | 0.32 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1,026.35) | (850.96) | (758.08) | (457.63) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,150.29 | 1,015.79 | 860.76 | 551.99 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (17.54%) | (4.81%) | (10.05%) | (38.07%) | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (86.49%) | (47.35%) | (54.54%) | (92.95%) | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (18.23%) | (5.04%) | (10.53%) | (41.52%) | — | — | — |
ROE
|
Analyst Commentary (Summary)
Nano Dimension Ltd. (NNDM) Latest News
17 Aug
Nano Dimension Ltd. appoints Nadav Kidron to board of directors to chair strategy and capital allocation committee. Appointment to chair strategy and capital allocation committee introduces potential influence on company decisions and resource allocation.
6 Aug
Nano Dimension Ltd. (NNDM) reported its financial results for the second quarter of 2026. Quarterly earnings release supplies updated financial metrics that may shift near-term valuation and sentiment.
20 Jul
Nano Dimension Ltd. and Murchinson reached an agreement to reconstitute the company's board of directors. Board reconstitution via investor agreement may shift governance and strategy without immediate financial overhaul.
14 Jul
Nano Dimension (NNDM) issues update on Infinite Epigenetics combination. Update on corporate combination signals major strategic move likely to alter company trajectory.
9 Jul
Nano Dimension board denounces Murchinson campaign as self-interested and destructive while defending its positions in ongoing dispute. Activist campaign and board rebuttal signal potential leadership or strategy shifts affecting company direction.
Nano Dimension board rebuts Murchinson campaign as self-interested and destructive. Activist campaign response may sway shareholder votes and short-term stock sentiment.
17 Jun
Nano Dimension and Infinite Epigenetics released additional details on their proposed business combination. Proposed business combination signals major strategic move likely to alter company trajectory and investor sentiment.
16 Jun
Nano Dimension Ltd. and Infinite Epigenetics released additional details on their proposed business combination. Proposed business combination constitutes a major strategic move likely to reshape Nano Dimension's operations and market trajectory.
15 Jun
Nano Dimension Ltd. signed a term sheet with Infinite Epigenetics to form a new publicly traded AI-powered preventive health and diagnostics company. Term sheet launches major strategic move into new AI health diagnostics business outside Nano Dimension core operations.
Nano Dimension Ltd. signed a term sheet with Infinite Epigenetics to form a new publicly traded AI-powered company focused on preventive health and diagnostics. Formation of a new AI health entity represents a major strategic diversification that can materially shift NNDM's business focus and investor perception.
Murchinson criticizes Nano Dimension board for pursuing a deeply flawed transaction with Infinite Epigenetics. Activist criticism of the deal may sway near-term investor sentiment and highlight governance concerns without altering core operations.
11 Jun
Murchinson invites Nano Dimension shareholders to a survey asking what trendy industry the board under Chairman Bob Pons plans to chase next. Shareholder survey questions board strategy and may pressure governance or influence sentiment.
5 Jun
Nano Dimension Ltd. (NNDM) issued a letter from Chief Executive Officer David Stehlin. CEO letter may signal strategic updates with moderate effects on operations and sentiment.
27 May
Nano Dimension Ltd. sold MarkForged, Inc. to Stratasys. Divestiture of MarkForged delivers cash and refocuses NNDM operations with direct effects on valuation and strategy.
26 May
Murchinson invites fellow Nano Dimension shareholders to an investor call to discuss the company's current state. Shareholder call invitation signals potential activism that may pressure governance without immediate operational overhaul.
Nano Dimension Ltd. issued a letter to shareholders. Shareholder letter may convey strategy or updates with moderate market influence.
Nano Dimension Ltd. issues letter to shareholders. Shareholder letter may shape investor views on strategy and performance.
9 May
Nano Dimension Ltd. (NNDM) released Q1 2026 earnings call transcript detailing quarterly financial results, operational updates, and management outlook. Q1 2026 earnings transcript provides key financial metrics, guidance, and strategic insights directly influencing investor sentiment and stock trajectory.
8 May
Nano Dimension Ltd. (NNDM) released Q1 earnings call highlights, covering financial results, strategic updates on additive manufacturing, acquisitions, and outlook amid market challenges. Q1 earnings highlights provide insights into financial performance and strategy, moderately influencing investor sentiment and stock trajectory.
7 May
Nano Dimension Ltd. (NNDM) released Q4 2025 earnings call transcript detailing financial results, operational updates, and future outlook. Q4 earnings transcripts disclose financial performance, guidance, and strategy, significantly influencing NNDM stock price and investor sentiment.
Nano Dimension Ltd. (NNDM) announced financial results for the first quarter of 2026. Quarterly earnings announcements typically drive significant stock volatility and shape investor expectations for future performance.
6 Apr
Nano Dimension Ltd. (NNDM) announces the sale of its AME and Fabrica product lines. Divesting AME and Fabrica product lines marks a major strategic shift reshaping Nano Dimension's portfolio and future focus.
31 Mar
Nano Dimension Ltd. (NNDM) Q4 2025 earnings call highlights reveal surpassing expectations amid challenges, with strong revenue growth, improved margins, and optimistic guidance for future expansion in additive manufacturing. Surpassing Q4 2025 earnings expectations signals significant financial strength and positive market sentiment shift for NNDM.
Nano Dimension Ltd. released Q4 earnings call highlights, detailing financial results, revenue growth in additive manufacturing, strategic acquisitions, operational efficiencies, and optimistic 2024 outlook amid market challenges. Q4 earnings highlights outline significant strategic initiatives and financial performance shifts poised to alter Nano Dimension's growth trajectory and investor sentiment.
Nano Dimension Ltd. (NNDM) announced financial results for the fourth quarter and full year 2025. Quarterly and annual earnings releases significantly influence financial performance assessments and market trajectory.
2 Feb
Nano Dimension Ltd. has adopted a limited duration shareholder rights agreement aimed at protecting the company from potential hostile takeovers. This agreement is designed to enhance shareholder value and ensure that any acquisition attempts are conducted fairly. The rights agreement will expire in 2024 unless extended, and it is part of the company's strategy to maintain control over its operations and future direction. The adoption of a shareholder rights agreement may moderately influence investor sentiment and corporate governance but is not expected to drastically change the company's trajectory.
21 Jan
Nano Dimension Ltd. reported fourth quarter 2025 revenue that exceeded guidance, highlighting strong financial performance. The company provided updates on its business strategy and product developments, indicating a positive outlook for future growth. Key initiatives and advancements in technology were also outlined, reinforcing the company's position in the market. Exceeding revenue guidance and strategic updates suggest significant potential for future growth and market performance.
17 Dec
Nano Dimension Ltd. (NNDM) is highlighted alongside two other penny stocks that exhibit promising potential for investors. The article discusses the company's advancements in 3D printing technology and its strategic initiatives aimed at enhancing market presence. Investors are encouraged to consider these stocks for potential growth opportunities in the current market landscape. The company's advancements and strategic initiatives may moderately influence its market performance and investor sentiment.
4 Dec
Nano Dimension Ltd. announced the results of its Annual General Meeting of Shareholders, where shareholders voted on various proposals, including the election of directors and approval of financial statements. The company reported a strong turnout and expressed gratitude for shareholder participation. Key resolutions were passed, reflecting confidence in the company's strategic direction and governance. Shareholder approval of key proposals may influence governance and operational strategies but is not expected to drastically change the company's trajectory.
20 Nov
Nano Dimension Ltd. (NNDM) reported strong revenue growth in Q3 2025, highlighting significant advancements in its product offerings and market expansion. The company emphasized its commitment to innovation and strategic investments, which are expected to enhance its competitive position in the 3D printing industry. Management expressed optimism about future performance, driven by increasing demand for advanced manufacturing solutions. Strong revenue growth and strategic investments indicate a significant impact on future performance and market positioning.
Nano Dimension Ltd. (NNDM), a leader in high-precision additive manufacturing for electronics, has delivered explosive revenue growth from $46,000 in 2016 to $57.8 million in 2024, with gross margins improving to 43% and a robust balance sheet featuring $758 million in net cash—nearly twice its market cap. However, this progress came at the cost of massive share dilution, ballooning outstanding shares from 1.8 million to 218 million, persistent net losses (narrowing to $97 million in 2024), and stock volatility that saw shares plummet from 2021 highs of $17.89 to 2024 lows near $2.
Despite these scars, NNDM trades at a discount to peers with a PS ratio of 9.4x and PB around 0.6x, while consensus analyst targets suggest 426% upside, driven by potential catalysts like new product launches, defense sector tailwinds, and cash-fueled buybacks or acquisitions. With improving profitability metrics and a multi-year runway, the company stands at a pivotal moment—poised for a turnaround or vulnerable to execution risks and macro pressures.